Clinical and psychological factors associated with resilience in patients with schizophrenia: data from the Italian network for research on psychoses using machine learning.

Italian network for research on psychoses machine learning personalized interventions resilience schizophrenia

Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
09 2023
Historique:
medline: 23 10 2023
pubmed: 12 10 2022
entrez: 11 10 2022
Statut: ppublish

Résumé

Resilience is defined as the ability to modify thoughts to cope with stressful events. Patients with schizophrenia (SCZ) having higher resilience (HR) levels show less severe symptoms and better real-life functioning. However, the clinical factors contributing to determine resilience levels in patients remain unclear. Thus, based on psychological, historical, clinical and environmental variables, we built a supervised machine learning algorithm to classify patients with HR or lower resilience (LR). SCZ from the Italian Network for Research on Psychoses ( The algorithm classified patients as HR or LR with a Balanced Accuracy of 74.5% ( We identified an accurate, meaningful and generalizable clinical-psychological signature associated with resilience in SCZ. This study delivers relevant information regarding psychological and clinical factors that non-pharmacological interventions could target in schizophrenia.

Sections du résumé

BACKGROUND
Resilience is defined as the ability to modify thoughts to cope with stressful events. Patients with schizophrenia (SCZ) having higher resilience (HR) levels show less severe symptoms and better real-life functioning. However, the clinical factors contributing to determine resilience levels in patients remain unclear. Thus, based on psychological, historical, clinical and environmental variables, we built a supervised machine learning algorithm to classify patients with HR or lower resilience (LR).
METHODS
SCZ from the Italian Network for Research on Psychoses (
RESULTS
The algorithm classified patients as HR or LR with a Balanced Accuracy of 74.5% (
CONCLUSIONS
We identified an accurate, meaningful and generalizable clinical-psychological signature associated with resilience in SCZ. This study delivers relevant information regarding psychological and clinical factors that non-pharmacological interventions could target in schizophrenia.

Identifiants

pubmed: 36217912
doi: 10.1017/S003329172200294X
pii: S003329172200294X
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5717-5728

Auteurs

Linda A Antonucci (LA)

Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Giulio Pergola (G)

Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Antonio Rampino (A)

Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Paola Rocca (P)

Department of Neuroscience, Section of Psychiatry, University of Turin, Turin, Italy.

Alessandro Rossi (A)

Section of Psychiatry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Mario Amore (M)

Section of Psychiatry, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy.

Eugenio Aguglia (E)

Department of Clinical and Molecular Biomedicine, Psychiatry Unit, University of Catania, Catania, Italy.

Antonello Bellomo (A)

Psychiatry Unit, Department of Medical Sciences, University of Foggia, Foggia, Italy.

Valeria Bianchini (V)

Unit of Psychiatry, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Claudio Brasso (C)

Department of Neuroscience, Section of Psychiatry, University of Turin, Turin, Italy.

Paola Bucci (P)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Bernardo Carpiniello (B)

Section of Psychiatry, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cagliari, Italy.

Liliana Dell'Osso (L)

Section of Psychiatry, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Fabio di Fabio (F)

Department of Neurology and Psychiatry, "La Sapienza" University of Rome, Rome, Italy.

Massimo di Giannantonio (M)

Department of Neuroscience and Imaging, "G. D'Annunzio" University, Chieti, Italy.

Andrea Fagiolini (A)

Department of Molecular Medicine and Clinical Department of Mental Health, University of Siena, Siena, Italy.

Giulia Maria Giordano (GM)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Matteo Marcatilli (M)

Department of Psychiatry, University of Milan, Milan, Italy.

Carlo Marchesi (C)

Department of Neuroscience, Psychiatry Unit, University of Parma, Parma, Italy.

Paolo Meneguzzo (P)

Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy.

Palmiero Monteleone (P)

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana" Section of Neuroscience, University of Salerno, Salerno, Italy.

Maurizio Pompili (M)

Department of Neurosciences, Mental Health and Sensory Organs, S. Andrea Hospital, "La Sapienza" University of Rome, Rome, Italy.

Rodolfo Rossi (R)

Section of Psychiatry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Alberto Siracusano (A)

Department of Systems Medicine, Psychiatry and Clinical Psychology Unit, "Tor Vergata" University of Rome, Rome, Italy.

Antonio Vita (A)

Psychiatric Unit, School of Medicine, University of Brescia, Brescia, Italy.
Department of Mental Health, Spedali Civili Hospital, Brescia, Italy.

Patrizia Zeppegno (P)

Department of Translational Medicine, Psychiatric Unit, University of Eastern Piedmont, Novara, Italy.

Silvana Galderisi (S)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Alessandro Bertolino (A)

Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Mario Maj (M)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH